More recently, whole-transcriptome analysis in patients with intracerebral hemorrhage correlated to neuroinflammation revealed a connection between DDX24 and Sphingosine 1-phosphate receptor 1 that is a target of the treatment of relapsing MS with Fingolimod [44]. Here, DDX24 is linked to myeloid sarcoma.